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Background: Cardiac resynchronization therapy-defibrillator [CRT-D] implantation has demonstrated to reduce mortality in selected heart 
failure patients. Small studies report patients with major improvement in left ventricular ejection fraction. Data of prognosis in these CRT-D super 
responders is scarce.
methods: All patients who underwent CRT-D implantation at Leiden University Medical Center are divided in subgroups according reduction of left 
ventricular end-systolic volume [LVESV], 6 months after implantation. Subgroups are: negative responders (increased LVESV) and super responders 
(decreased LVESV>30%), remaining patients are excluded. For deceased, mode of death is retrieved from hospital or general practitioner records. 
results: Of 1312 CRT-D recipients, this study includes 445 patients (215 negative; 230 super responders). During a median follow up of 47±41 
months, 84 (39%) negative and 52 (23%) super responders died (p=0.001). Cardiac death occurred in 43 (51%) negative and 18 (35%) super 
responders (p=0.07), from which 35 (42%) negative and 13 (25%) super responders died of heart failure (p<0.05). Non cardiac death occurred 24 
(29%) negative and 25 (48%) super responders (p=0.001), respectively 6 (7%) and 11 (21%) died due to malignant neoplasm (p<0.01). 
conclusions: In clinical practice CRT-D super responders have lower mortality compared to negative responders. Super responders die less of 
cardiac deaths (heart failure), but more of non cardiac death (malignant neoplasm).
 
